Quantum Biopharma (QNTM) Enterprise Value (2018 - 2026)
Quantum Biopharma (QNTM) reported Enterprise Value of -$6.6 million for Q1 2026, down 38.74% on a YoY basis from -$10.7 million in Q1 2025, and down 57.18% sequentially from -$4.2 million in Q4 2025.
Quantum Biopharma (QNTM) Enterprise Value (2018 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 9 years of Enterprise Value data on file, last reported at -$6.6 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 38.74% year-over-year to -$6.6 million; the trailing twelve-month figure through Mar 2026 stood at -$6.6 million (down 38.74% YoY), and the FY2025 full-year result was -$4.2 million, up 49.19% from the prior year.
- Enterprise Value declined to -$6.6 million in Q1 2026, from -$4.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.2 million in Q3 2025 to a low of -$32.0 million in Q2 2022.
- A 5-year average of -$10.9 million and a median of -$6.6 million in 2026 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 81.49% in 2023 and sank 69.17% in 2024, its largest moves.
- Tracing QNTM's Enterprise Value over 5 years: stood at -$17.0 million in 2022, then surged by 73.72% to -$4.5 million in 2023, then plunged by 84.59% to -$8.2 million in 2024, then surged by 49.19% to -$4.2 million in 2025, then sank by 57.18% to -$6.6 million in 2026.
- Business Quant data shows QNTM's Enterprise Value at -$6.6 million in Q1 2026, -$4.2 million in Q4 2025, and -$2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | -6.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.58 Mn |
| Dec 31, 2025 | -4.19 Mn |
| Sep 30, 2025 | -2.23 Mn |
| Jun 30, 2025 | -3.25 Mn |
| Mar 31, 2025 | -4.74 Mn |
| Dec 31, 2024 | -8.24 Mn |
| Sep 30, 2024 | -7.55 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Sep 30, 2023 | -4.46 Mn |
| Jun 30, 2023 | -6.22 Mn |
| Mar 31, 2023 | -9.87 Mn |
| Dec 31, 2022 | -16.98 Mn |
| Sep 30, 2022 | -24.11 Mn |
| Jun 30, 2022 | -31.98 Mn |
| Mar 31, 2022 | -29.11 Mn |
| Dec 31, 2021 | -35.42 Mn |
| Sep 30, 2021 | -40.81 Mn |
| Jun 30, 2021 | -45.45 Mn |
| Mar 31, 2021 | -52.48 Mn |
| Dec 31, 2020 | -17.52 Mn |